InvestorsHub Logo
Followers 9
Posts 432
Boards Moderated 0
Alias Born 01/20/2014

Re: None

Tuesday, 09/05/2023 2:13:33 AM

Tuesday, September 05, 2023 2:13:33 AM

Post# of 402526
The U.S. Food and Drug Administration had said on Monday it has approved generic versions of Vyvanse from 11 drugmakers after Takeda's exclusivity over the drug expired on Aug. 24. Copycats of the drug come in capsules and chewable tablets, ranging between 10 milligrams to 70 milligram doses.

https://www.reuters.com/business/healthcare-pharmaceuticals/generic-drugmakers-start-shipping-copies-takedas-adhd-drug-vyvanse-2023-08-31/

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-multiple-generics-adhd-and-bed-treatment
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News